Detalhe da pesquisa
1.
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
Blood
; 140(24): 2533-2548, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969835
2.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914826
3.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
4.
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Cancer
; 129(8): 1205-1216, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738229
5.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779595
6.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443559
7.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
8.
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Am J Hematol
; 98(11): 1780-1790, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665752
9.
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Blood
; 135(6): 449-452, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826244
10.
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Haematologica
; 107(4): 844-856, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435482
11.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
12.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
13.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438043
14.
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Cancer
; 126(10): 2183-2192, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101640
15.
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer
; 126(10): 2193-2205, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125707
16.
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Blood
; 131(11): 1248-1257, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386198
17.
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 22(5): e13395, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602954
18.
Characterization of Viral Infections after Antithymocyte Globulin-Based Conditioning in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1837-1843, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128324
19.
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 25(3): 505-514, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308325
20.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826465